inhalation aerosol Articles
Teva's ProAir approved for four-year olds
29 September 2008
Symbicort sees similar safety to budesonide
1 September 2008
AZ submits sNDA for Symbicot in pediatric asthma
9 June 2008
FDA says CFC inhalers will cease end 2008
9 June 2008
EPO revokes a Symbicort patent
12 May 2008
AstraZeneca submits Symbicort sNDA to US FDA
5 May 2008
Nycomed licenses US rights to ciclesonide drugs to Sepracor in deal worth up to $430M
4 February 2008
Teva enters drug alliance with UCB in USA
21 January 2008
FDA approves GSK's Flovent in children aged four to 11
27 March 2006
FDA OKs Sepracor's Xophenex metered-dose inhaler
21 March 2005
Aventis sells Azmacort to Kos for $200m
15 March 2004
Astra USA Wins Sex Allegations Appeal
16 September 1996
GW's Flovent Approved In USA
8 April 1996
BOEHRINGER INGELHEIM RECEIVES NOT APPROVABLE LETTER
14 March 1994
GLAXO'S SEREVENT GAINS US APPROVAL
14 February 1994
BOEHRINGER INGELHEIM GETS GO-AHEAD FOR US TRIALS
19 July 1993
Showing 1-17 of 17 articles
- 1
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Italy's pharma market slump set to continue, warns GlobalData
- Is failure to adopt business process management putting the pharma industry at risk?
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
